Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients — Stella

Recruiting

Back to Acute T Cell Lymphoblastic Leukemia trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(1 site)

China

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu

Key details

Phase

Large-scale testing

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

Children's Hospital of Soochow University, Ruijin Hospital

Enrollment target

~146 participants

Started

April 2024

Primary completion

March 2028

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov